Advancing Personalized Therapy for Advanced Non-Small Cell Lung Cancer

Advancing Personalized Therapy for Advanced Non-Small Cell Lung Cancer

VeriStrat (Biodesix) is a serum proteomic test for patients with advanced non-small cell lung cancer (NSCLC) that helps healthcare provides select therapy when considering erlotinib (Tarceva®, Genentech) or single-agent chemotherapy. It is a blood-based test that provides rapid, easy-to-understand results, simplifying therapy selection for healthcare providers and their oncology teams.

Order a free copy of a White Paper which reviews current practice in managing advanced NSCLC and puts VeriStrat in its appropriate context for oncology nurses. Biodesix and ONS:Edge are pleased to provide, ONS:Edge White Paper: Advancing Personalized Therapy for Advanced Non-Small Cell Lung Cancer.

Please be advised the VeriStrat Support Hotline telephone number is 1-866-432-5930

  • Nursing
  • Nursing
  • Nursing

ONS:Edge Nursing Resources

ONS:Edge offers oncology nurses and other healthcare professionals a selection of free resources for use in daily practice covering topics ranging from patient counseling to cancer-related spinal fractures.

Check back often for new resources!